US Stock MarketDetailed Quotes

JAZZ Jazz Pharmaceuticals

Watchlist
  • 133.960
  • -2.860-2.09%
Close Feb 14 16:00 ET
  • 133.960
  • 0.0000.00%
Post 20:01 ET
8.10BMarket Cap18.97P/E (TTM)

About Jazz Pharmaceuticals Company

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

Company Profile

SymbolJAZZ
Company NameJazz Pharmaceuticals
Listing DateJun 1, 2007
Issue Price18.00
Founded2005
CEOMr. Bruce C. Cozadd
MarketNASDAQ
Employees2800
Fiscal Year Ends12-31
AddressWaterloo Exchange,Waterloo Road,5th Floor
CityDublin
ProvinceDublin
CountryIreland
Zip Code4
Phone353-1-634-7800
Websitehttp://www.jazzpharmaceuticals.com

Company Executives

  • Name
  • Position
  • Salary
  • Bruce C. Cozadd
  • Chairman of the Board and Chief Executive Officer
  • 15.34M
  • Renee D. Gala
  • President and Chief Operating Officer
  • 5.43M
  • Patricia Carr
  • Senior Vice President and Chief Accounting Officer
  • 1.40M
  • Philip L. Johnson
  • Executive Vice President and Chief Financial Officer
  • --
  • Neena M. Patil
  • Executive Vice President and Chief Legal Officer
  • 3.88M
  • Liz Henderson
  • Senior Vice President, Technical Operations
  • --
  • Samantha Pearce
  • Senior Vice President, Europe and International
  • --
  • Dr. Robert Iannone, M.D.
  • Executive Vice President and Global Head of Research and Development
  • 4.98M
  • Kenneth W. O'Keefe
  • Independent Director
  • 513.77K
  • Laura J. Hamill
  • Independent Director
  • --
  • Patrick G. Enright, M.B.A.
  • Independent Director
  • 526.27K
  • Dr. Mark D. Smith, M.D.
  • Independent Director
  • 521.27K
  • Dr. Norbert G. Riedel,PhD
  • Independent Director
  • 533.77K
  • Anne O'Riordan
  • Independent Director
  • 523.77K
  • Patrick Thomas Kennedy
  • Independent Director
  • --
  • Rick E. Winningham
  • Lead Independent Director
  • 571.27K
  • Jennifer E. Cook
  • Independent Director
  • 533.77K
  • Seamus C. Mulligan
  • Independent Director
  • 531.27K
  • Heather Ann McSharry
  • Independent Director
  • 543.77K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
XINGANJIANG
873167
+30.00%
INNOVATIVE DATA
835305
+29.98%
CHENGUANG MEDICAL
430300
+29.96%
4
Hangzhou Gaoxin Materials Technology
300478
+20.04%
5
Beijing Philisense Technology
300287
+20.03%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
Many institutions are bullish! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1 Show More
China's asset revaluation sparks debate: What are mooers buying?